BHC Bausch Health Companies Earnings and EPS analysis

Relative Growth: Rel. Growth: 35

Relative Strength: Rel. Strength: 52

Relative Valuation: Rel. Valuation: 56

Relative Profitability: Rel. Profitability: 33

EPS in 2026 (TTM): -$2.96

Last Report Period Date: Jun 30, 2026

According to the most recent financial data from June 2026, the EPS for the trailing twelve months is -$2.96. Bausch Health Companies's EPS for 2025 amounted to $0.42, marking an increase from -$0.13 in 2024. During the quarterly period ending on Jun 30, 2026, BHC's EPS stood at $0.69.

BHC earnings history

Historical annual and quarterly earnings per share (EPS) data for Bausch Health Companies

EPS (TTM)

-$2.96

EPS Growth YoY (Quarterly)

72.5%

EPS (Quarterly)

$0.69

EPS Growth (Quarterly)

118.1%

Bausch Health Companies had an annual EPS of $0.42, indicating an increase of 423.1% from -$0.13 in 2024. The quarterly per-share earnings for the period ending Jun 30, 2026, was $0.69, indicating a 72.5% increase from the same quarter last year. BHC's 12-month EPS stands at -$2.96 as of June 2026. Bausch Health Companies's annual EPS in 2024 stood at -$0.13, a 92% increase year-over-year.

BHC EPS vs price chart

BHC EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

72.5%

EPS growth YoY

423.1%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Bausch Health Companies has registered an increase in EPS of 72.5% during the last 12 months (YoY, quarterly).

BHC Earnings Waterfall

Breakdown of revenue, profit and net income for Bausch Health Companies

BHC Earnings vs Peers

What are the earnings of BHC compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
OPK Opko Health Inc	N/A	-275%	N/A	N/A
ORGO Organogenesis Holdings Inc	N/A	1,700%	10.1%	0%
BHC Bausch Health Companies Inc	N/A	423.1%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.